135 related articles for article (PubMed ID: 6169424)
41. [Palliation of brain metastases: factors associated with survival].
Kutuki S; Ito H; Shigematsu N; Toya K; Ka WJ; Tsukamoto N; Kumagaya H; Uematsu M; Kubo A
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):426-31. PubMed ID: 8710467
[TBL] [Abstract][Full Text] [Related]
42. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
43. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
44. A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases.
Rades D; Janssen S; Bajrovic A; Khoa MT; Veninga T; Schild SE
Radiat Oncol; 2017 Apr; 12(1):69. PubMed ID: 28438175
[TBL] [Abstract][Full Text] [Related]
45. Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
Hansen HC; Janssen S; Thieme C; Perlov A; Schild SE; Rades D
Anticancer Res; 2019 Mar; 39(3):1343-1346. PubMed ID: 30842167
[TBL] [Abstract][Full Text] [Related]
46. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
47. Whole brain radiotherapy for the treatment of multiple brain metastases.
Tsao MN; Lloyd N; Wong R; Chow E; Rakovitch E; Laperriere N
Cochrane Database Syst Rev; 2006 Jul; (3):CD003869. PubMed ID: 16856022
[TBL] [Abstract][Full Text] [Related]
48. Palliative radiotherapy in the UK.
Priestman TJ
Can J Oncol; 1996 Feb; 6 Suppl 1():69-73; discussion 84. PubMed ID: 8853541
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
50. Palliative care in patients who receive whole brain radiotherapy for brain metastases in Ahmadu Bello University Teaching Hospital, Zaria.
Osinde TA; Adamu A; Jimeta JD; Chukwuocha IC
Niger J Med; 2016; 25(3):215-9. PubMed ID: 30011165
[TBL] [Abstract][Full Text] [Related]
51. Recursive Partitioning Analysis Groups II-III brain metastases of non-small cell lung cancer: a phase II randomized study comparing two concurrent chemoradiotherapy regimens.
Quantin X; Bozonnat MC; Pujol JL
J Thorac Oncol; 2010 Jun; 5(6):846-51. PubMed ID: 20421817
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors affecting the outcome of brain metastases from breast cancer.
Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
[TBL] [Abstract][Full Text] [Related]
53. Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis.
Buecker R; Hong ZY; Liu XM; Jaenke G; Lu P; Schaefer U
Radiat Oncol; 2019 Mar; 14(1):41. PubMed ID: 30866972
[TBL] [Abstract][Full Text] [Related]
54. [Cerebral metastases: radiotherapy and chemotherapy].
Helfre S; Pierga J
Neurochirurgie; 1999 Dec; 45(5):382-92. PubMed ID: 10717587
[TBL] [Abstract][Full Text] [Related]
55. [Guidelines for the diagnosis and management of brain metastases].
Juozaityte E
Medicina (Kaunas); 2003; 39(8):804-11. PubMed ID: 12960461
[TBL] [Abstract][Full Text] [Related]
56. Surgical management of single and multiple brain metastases: results of a retrospective study.
Schackert G; Steinmetz A; Meier U; Sobottka SB
Onkologie; 2001 Jun; 24(3):246-55. PubMed ID: 11455217
[TBL] [Abstract][Full Text] [Related]
57. Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.
Sun H; Xu L; Wang Y; Zhao J; Xu K; Qi J; Yuan Z; Zhao L; Wang P
Radiat Oncol; 2018 Dec; 13(1):250. PubMed ID: 30563554
[TBL] [Abstract][Full Text] [Related]
58. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
59. [Results of radiotherapy in brain metastasis].
Schultze J; Kaya A; Kimmig B
Rontgenpraxis; 2000; 53(3):102-9. PubMed ID: 11131110
[TBL] [Abstract][Full Text] [Related]
60. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.
Milano MT; Zhang H; Metcalfe SK; Muhs AG; Okunieff P
Breast Cancer Res Treat; 2009 Jun; 115(3):601-8. PubMed ID: 18719992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
